Department of Pharmacology, Paediatrics and Organic Chemistry, Miguel Hernández University of Elche, Crta. Nacional, N-332. S/N, Sant Joan, 03550, Alicante, Spain.
Neuropharmacology on Pain and Functional Diversity (NED), Institute of Health and Biomedical Research of Alicante (ISABIAL Foundation), Alicante, Spain.
Sports Med. 2023 Jun;53(6):1273-1279. doi: 10.1007/s40279-023-01819-y. Epub 2023 Feb 24.
Nicotine is a psychostimulant drug with purported use in sports environments, though the use of nicotine among athletes has not been studied extensively.
The aim of this study was to assess the nicotine positivity rate in 60,802 anti-doping urine samples from 2012 to 2020.
Urine samples obtained in-competition at different national and international sports events held in Italy during the period 2012-2020 were analysed. All samples were from anonymous athletes that were collected and analysed at the WADA-accredited antidoping laboratory in Rome, Italy. Samples were analysed by gas chromatography coupled with mass spectrometry, with a cut-off concentration for nicotine of > 50 ng/mL. Results were stratified by year, sport and sex.
An overall mean of 22.7% of the samples (n = 13,804; males: n = 11,099; females: n = 2705) showed nicotine intake, with male samples also displaying higher positivity rates than female (24.1% vs 18.5%). Sample positivity was higher during 2012-2014 (25-33%) than 2015-2020 (15-20%). Samples from team sports displayed a higher positivity rate than those from individual sports (31.4 vs 14.1%).
The current data demonstrates that one in five samples from a range of 90 sports test positive for nicotine in-competition. There is a lower positivity rate in endurance versus power/strength athletes and higher positivity rate in team versus individual sports, probably accounted for by differences in physiological and psychological demands and the desire for socialisation. WADA, international and national sports federations should consider these findings with concern, proactively investigate this phenomenon and act in order to protect the health and welfare of its athletes.
尼古丁是一种精神兴奋剂药物,据称在运动环境中有使用,但运动员使用尼古丁的情况尚未得到广泛研究。
本研究旨在评估 2012 年至 2020 年期间,60802 份反兴奋剂尿样中的尼古丁阳性率。
分析了 2012-2020 年期间在意大利举行的不同国家和国际体育赛事中获得的比赛内尿液样本。所有样本均来自匿名运动员,由意大利世界反兴奋剂机构认可的反兴奋剂实验室采集和分析。样本通过气相色谱-质谱联用进行分析,尼古丁的截断浓度为>50ng/mL。结果按年份、运动项目和性别进行分层。
总体而言,22.7%的样本(n=13804;男性:n=11099;女性:n=2705)显示尼古丁摄入,男性样本的阳性率也高于女性(24.1%比 18.5%)。2012-2014 年(25-33%)样本阳性率高于 2015-2020 年(15-20%)。团队运动的样本阳性率高于个人运动(31.4%比 14.1%)。
目前的数据表明,来自 90 种运动的样本中,有五分之一在比赛中检测出尼古丁阳性。与耐力运动员相比,力量/强度运动员的阳性率较低,与个人运动相比,团队运动的阳性率较高,这可能是由于生理和心理需求以及社交需求的差异所致。世界反兴奋剂机构、国际和国家体育联合会应关注这些发现,主动调查这一现象,并采取行动保护其运动员的健康和福利。